Drug Information

Product NDC: 64679-670

Proprietary Name: Lansoprazole

Non Proprietary Name: Lansoprazole

Active Ingredient(s):
  • 30 mg/1 LANSOPRAZOLE

Administration Route(s): ORAL


Pharmacy Class(es):
  • Proton Pump Inhibitor [EPC];
  • Proton Pump Inhibitors [MoA];
  • Inhibition Gastric Acid Secretion [PE]

Labeler Information

Labeler Name: Wockhardt USA LLC.
FDA Application Number: ANDA202176
Marketing Category: ANDA
Start Marketing Date:9/14/2012

Package Information

No. Package Code Package Description Billing Unit
164679-670-0130 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64679-670-01)EA
264679-670-0260 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64679-670-02)
364679-670-03100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64679-670-03)
464679-670-04500 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64679-670-04)
564679-670-051000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64679-670-05)EA
664679-670-0610 BLISTER PACK in 1 CARTON (64679-670-06) > 10 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK
764679-670-0790 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64679-670-07)EA

NDC Record

Field Name Field Value Definition
PRODUCT NDC64679-670The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN PRESCRIPTION DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMELansoprazoleThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMELansoprazoleThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMECAPSULE, DELAYED RELEASEThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE9/14/2012This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEANDAProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERANDA202176This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMEWockhardt USA LLC.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMELANSOPRAZOLEThis is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
PHARM CLASSESProton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Inhibition Gastric Acid Secretion [PE] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 5/20/2020